Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation; Stroke Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01855139
What this trial is testing

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism

Who this might be right for
Atrial Fibrillation
Bayer 106
Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableStudy completedNCT03572972
What this trial is testing

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

Who this might be right for
Atrial Fibrillation
Pfizer 64,684
Not applicableStudy completedNCT02657616
What this trial is testing

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

Who this might be right for
Atrial FibrillationStroke Prophylaxis
Institut für Pharmakoökonomie und Arzneimittellogistik e.V. 204,464
Large-scale testing (Phase 3)Looking for participantsNCT07626411
What this trial is testing

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals 15,364
Not applicableStudy completedNCT04233515
What this trial is testing

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

Who this might be right for
Atrial FibrillationStroke, Ischemic
Region Örebro County 11,964
Not applicableUnknownNCT04419012
What this trial is testing

Polish Atrial Fibrillation (POL-AF) Registry

Who this might be right for
Atrial Fibrillation
Jan Kochanowski University 4,000
Not applicableActive Not RecruitingNCT04371055
What this trial is testing

Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study

Who this might be right for
Ischemic StrokeAtrial Fibrillation
University of Leipzig 5,227
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Not applicableStudy completedNCT01721837
What this trial is testing

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,340
Large-scale testing (Phase 3)Study completedNCT00403767
What this trial is testing

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeEmbolism
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT03746301
What this trial is testing

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 924
Not applicableStudy completedNCT01947985
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 208,958
Not applicableUnknownNCT03651323
What this trial is testing

Latin America Registry on WatchmanTM Outcomes in Real Life

Who this might be right for
Atrial Fibrillation
Centro Medico Docente la Trinidad 500
Not applicableUnknownNCT03327350
What this trial is testing

WATCHMAN for Second Prevention of Stroke (WASPS)

Who this might be right for
Atrial FibrillationStroke
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Not applicableLooking for participantsNCT07575867
What this trial is testing

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

Who this might be right for
Atrial FibrillationStroke Prevention in Patients With Atrial FibrillationLeft Atrial Appendage Closure+4 more
National Medical Research Center for Therapy and Preventive Medicine 464
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Post-approval studies (Phase 4)Study completedNCT02168829
What this trial is testing

Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Who this might be right for
Atrial FibrillationStroke
Ottawa Heart Institute Research Corporation 1,284
Not applicableStudy completedNCT02468102
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Who this might be right for
Acute Coronary SyndromeVenous ThrombosisPulmonary Embolism+1 more
Bayer 99,999
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Next Page